Matches in DBpedia 2016-04 for { ?s ?p "SB-431542 is a drug candidate developed by GlaxoSmithKline (GSK) as an inhibitor of the activin receptor-like kinase (ALK) receptors, ALK5, ALK4 and ALK7. (It is NOT an ALK inhibitor)."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- SB-431542 abstract "SB-431542 is a drug candidate developed by GlaxoSmithKline (GSK) as an inhibitor of the activin receptor-like kinase (ALK) receptors, ALK5, ALK4 and ALK7. (It is NOT an ALK inhibitor).".
- Q7388913 abstract "SB-431542 is a drug candidate developed by GlaxoSmithKline (GSK) as an inhibitor of the activin receptor-like kinase (ALK) receptors, ALK5, ALK4 and ALK7. (It is NOT an ALK inhibitor).".
- SB-431542 comment "SB-431542 is a drug candidate developed by GlaxoSmithKline (GSK) as an inhibitor of the activin receptor-like kinase (ALK) receptors, ALK5, ALK4 and ALK7. (It is NOT an ALK inhibitor).".
- Q7388913 comment "SB-431542 is a drug candidate developed by GlaxoSmithKline (GSK) as an inhibitor of the activin receptor-like kinase (ALK) receptors, ALK5, ALK4 and ALK7. (It is NOT an ALK inhibitor).".